GB2107585A - Animal feed supplements containing lysocellin - Google Patents
Animal feed supplements containing lysocellin Download PDFInfo
- Publication number
- GB2107585A GB2107585A GB08217753A GB8217753A GB2107585A GB 2107585 A GB2107585 A GB 2107585A GB 08217753 A GB08217753 A GB 08217753A GB 8217753 A GB8217753 A GB 8217753A GB 2107585 A GB2107585 A GB 2107585A
- Authority
- GB
- United Kingdom
- Prior art keywords
- lysocellin
- animal
- administered
- manganese
- feed
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- KTQFYFLZDLTLAH-UHFFFAOYSA-N Lysocellin Natural products CCC(O)C1(CC)CC(C)C(O)(O1)C2(C)CC(C)C(O2)C(CC)C(=O)C(C)C(O)C(C)C3OC(O)(CC(=O)O)C(C)CC3C KTQFYFLZDLTLAH-UHFFFAOYSA-N 0.000 title claims abstract description 117
- KTQFYFLZDLTLAH-DESDHLEASA-N lysocellin Chemical compound O1[C@]([C@@H](O)CC)(CC)C[C@@H](C)[C@]1(O)[C@@]1(C)O[C@H]([C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CC(O)=O)O2)C)[C@@H](C)C1 KTQFYFLZDLTLAH-DESDHLEASA-N 0.000 title claims abstract description 115
- 241001465754 Metazoa Species 0.000 title claims description 42
- 239000006052 feed supplement Substances 0.000 title claims 9
- 230000012010 growth Effects 0.000 claims abstract description 18
- 241000282849 Ruminantia Species 0.000 claims abstract description 16
- 239000010949 copper Substances 0.000 claims abstract description 12
- 229910052802 copper Inorganic materials 0.000 claims abstract description 11
- 235000013305 food Nutrition 0.000 claims abstract description 11
- 241000124008 Mammalia Species 0.000 claims abstract description 10
- 230000001737 promoting effect Effects 0.000 claims abstract description 7
- 150000003839 salts Chemical class 0.000 claims abstract description 7
- 229910052751 metal Inorganic materials 0.000 claims abstract 6
- 239000002184 metal Substances 0.000 claims abstract 6
- 239000000463 material Substances 0.000 claims description 40
- 238000000034 method Methods 0.000 claims description 27
- 239000011701 zinc Substances 0.000 claims description 21
- 210000004767 rumen Anatomy 0.000 claims description 18
- 229910052748 manganese Inorganic materials 0.000 claims description 17
- 239000011572 manganese Substances 0.000 claims description 17
- 229910052725 zinc Inorganic materials 0.000 claims description 17
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 claims description 15
- PWHULOQIROXLJO-UHFFFAOYSA-N Manganese Chemical compound [Mn] PWHULOQIROXLJO-UHFFFAOYSA-N 0.000 claims description 14
- 239000000203 mixture Substances 0.000 claims description 14
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 13
- 239000011734 sodium Substances 0.000 claims description 13
- 229910052708 sodium Inorganic materials 0.000 claims description 13
- 239000002253 acid Substances 0.000 claims description 12
- 239000012530 fluid Substances 0.000 claims description 10
- -1 copper lysocellin salts Chemical class 0.000 claims description 6
- 230000002708 enhancing effect Effects 0.000 claims description 5
- 230000001965 increasing effect Effects 0.000 claims description 4
- 230000004048 modification Effects 0.000 claims 2
- 238000012986 modification Methods 0.000 claims 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 abstract description 6
- 230000003115 biocidal effect Effects 0.000 abstract description 6
- KSHPUQQHKKJVIO-UHFFFAOYSA-N [Na].[Zn] Chemical compound [Na].[Zn] KSHPUQQHKKJVIO-UHFFFAOYSA-N 0.000 abstract description 2
- 150000002696 manganese Chemical class 0.000 abstract description 2
- 150000004696 coordination complex Chemical class 0.000 abstract 1
- 238000000855 fermentation Methods 0.000 description 12
- 230000004151 fermentation Effects 0.000 description 12
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 11
- 239000003242 anti bacterial agent Substances 0.000 description 11
- 229940088710 antibiotic agent Drugs 0.000 description 11
- 238000012360 testing method Methods 0.000 description 11
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 8
- 241000283903 Ovis aries Species 0.000 description 8
- 239000004721 Polyphenylene oxide Substances 0.000 description 8
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 8
- 150000001875 compounds Chemical class 0.000 description 8
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Chemical compound C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 8
- 229920000570 polyether Polymers 0.000 description 8
- ZFRKQXVRDFCRJG-UHFFFAOYSA-N skatole Chemical compound C1=CC=C2C(C)=CNC2=C1 ZFRKQXVRDFCRJG-UHFFFAOYSA-N 0.000 description 8
- 241000283690 Bos taurus Species 0.000 description 7
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 7
- 239000003795 chemical substances by application Substances 0.000 description 7
- 238000004519 manufacturing process Methods 0.000 description 7
- DIKYHBWGIUNGIW-UHFFFAOYSA-N 2-[2,4-dihydroxy-6-[1-[2-[5-[5-(6-hydroxy-4-methoxy-3,5,6-trimethyloxan-2-yl)oxolan-2-yl]-5-methyloxolan-2-yl]-7-methoxy-2,6-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]ethyl]-5-(5-methoxy-6-methyloxan-2-yl)oxy-3,5-dimethyloxan-2-yl]propanoic acid Chemical compound O1C(C)C(OC)CCC1OC1(C)C(C(C)C2OC3(OC(C)(CC3)C3OC(C)(CC3)C3OC(CC3)C3C(C(OC)C(C)C(C)(O)O3)C)C(C)C(OC)C2)OC(O)(C(C)C(O)=O)C(C)C1O DIKYHBWGIUNGIW-UHFFFAOYSA-N 0.000 description 6
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 6
- 229930191564 Monensin Natural products 0.000 description 6
- GAOZTHIDHYLHMS-UHFFFAOYSA-N Monensin A Natural products O1C(CC)(C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)CCC1C(O1)(C)CCC21CC(O)C(C)C(C(C)C(OC)C(C)C(O)=O)O2 GAOZTHIDHYLHMS-UHFFFAOYSA-N 0.000 description 6
- 150000001879 copper Chemical class 0.000 description 6
- 230000000694 effects Effects 0.000 description 6
- 238000000338 in vitro Methods 0.000 description 6
- 229960005358 monensin Drugs 0.000 description 6
- GAOZTHIDHYLHMS-KEOBGNEYSA-N monensin A Chemical compound C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C[C@@]21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C(O)=O)O2 GAOZTHIDHYLHMS-KEOBGNEYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- 150000001720 carbohydrates Chemical class 0.000 description 5
- 235000014633 carbohydrates Nutrition 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-M Butyrate Chemical compound CCCC([O-])=O FERIUCNNQQJTOY-UHFFFAOYSA-M 0.000 description 4
- FERIUCNNQQJTOY-UHFFFAOYSA-N Butyric acid Natural products CCCC(O)=O FERIUCNNQQJTOY-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- OPQARKPSCNTWTJ-UHFFFAOYSA-L copper(ii) acetate Chemical compound [Cu+2].CC([O-])=O.CC([O-])=O OPQARKPSCNTWTJ-UHFFFAOYSA-L 0.000 description 4
- 239000007943 implant Substances 0.000 description 4
- 239000007788 liquid Substances 0.000 description 4
- 244000144977 poultry Species 0.000 description 4
- 238000011282 treatment Methods 0.000 description 4
- DJWUNCQRNNEAKC-UHFFFAOYSA-L zinc acetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O DJWUNCQRNNEAKC-UHFFFAOYSA-L 0.000 description 4
- NZHCPUBOSWFGNA-MKODDJJXSA-N 3-chloro-2-[(2s,4r,5s,6s,8r)-8-[(1r,2r,3r,7r,9s,10s,12r,15r)-3-[(2r,4r)-5-ethoxycarbonyl-4-hydroxyoxolan-2-yl]-15-hydroxy-2-methoxy-1,3,10,12-tetramethyl-4,6,8-trioxadispiro[4.1.5^{7}.3^{5}]pentadec-13-en-9-yl]-5-hydroxy-4,6-dimethyl-7-oxononan-2-yl]-6-hy Chemical compound C1[C@@H](O)C(C(=O)OCC)O[C@H]1[C@]1(C)[C@H](OC)[C@@H](C)C2([C@@H](C=C[C@@]3([C@@H](C[C@H](C)[C@@H]([C@@H](C)C(=O)[C@@H](C)[C@@H](O)[C@H](C)C[C@H](C)C=4C(=C(O)C(C)=CC=4Cl)C(O)=O)O3)C)O2)O)O1 NZHCPUBOSWFGNA-MKODDJJXSA-N 0.000 description 3
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 3
- 241000970926 Streptomyces longwoodensis Species 0.000 description 3
- 239000003674 animal food additive Substances 0.000 description 3
- 239000011575 calcium Substances 0.000 description 3
- 229910052791 calcium Inorganic materials 0.000 description 3
- 230000015556 catabolic process Effects 0.000 description 3
- 238000006731 degradation reaction Methods 0.000 description 3
- 235000005911 diet Nutrition 0.000 description 3
- 235000014113 dietary fatty acids Nutrition 0.000 description 3
- 229930195729 fatty acid Natural products 0.000 description 3
- 239000000194 fatty acid Substances 0.000 description 3
- 150000004665 fatty acids Chemical class 0.000 description 3
- WPBNNNQJVZRUHP-UHFFFAOYSA-L manganese(2+);methyl n-[[2-(methoxycarbonylcarbamothioylamino)phenyl]carbamothioyl]carbamate;n-[2-(sulfidocarbothioylamino)ethyl]carbamodithioate Chemical compound [Mn+2].[S-]C(=S)NCCNC([S-])=S.COC(=O)NC(=S)NC1=CC=CC=C1NC(=S)NC(=O)OC WPBNNNQJVZRUHP-UHFFFAOYSA-L 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 244000005700 microbiome Species 0.000 description 3
- 238000001556 precipitation Methods 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229960004799 tryptophan Drugs 0.000 description 3
- 150000003751 zinc Chemical class 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 2
- 235000019750 Crude protein Nutrition 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical group Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- 229930182504 Lasalocid Natural products 0.000 description 2
- 235000019738 Limestone Nutrition 0.000 description 2
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 2
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 2
- LCTONWCANYUPML-UHFFFAOYSA-M Pyruvate Chemical compound CC(=O)C([O-])=O LCTONWCANYUPML-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- 241000187747 Streptomyces Species 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 240000008042 Zea mays Species 0.000 description 2
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 2
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 2
- 230000000845 anti-microbial effect Effects 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000003224 coccidiostatic agent Substances 0.000 description 2
- 235000005822 corn Nutrition 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- 229940076286 cupric acetate Drugs 0.000 description 2
- 230000000378 dietary effect Effects 0.000 description 2
- DANUORFCFTYTSZ-UHFFFAOYSA-N epinigericin Natural products O1C2(C(CC(C)(O2)C2OC(C)(CC2)C2C(CC(O2)C2C(CC(C)C(O)(CO)O2)C)C)C)C(C)C(OC)CC1CC1CCC(C)C(C(C)C(O)=O)O1 DANUORFCFTYTSZ-UHFFFAOYSA-N 0.000 description 2
- 239000000835 fiber Substances 0.000 description 2
- XLYOFNOQVPJJNP-ZSJDYOACSA-N heavy water Substances [2H]O[2H] XLYOFNOQVPJJNP-ZSJDYOACSA-N 0.000 description 2
- 125000000623 heterocyclic group Chemical group 0.000 description 2
- 229910052500 inorganic mineral Inorganic materials 0.000 description 2
- BBMULGJBVDDDNI-OWKLGTHSSA-N lasalocid Chemical compound C([C@@H]1[C@@]2(CC)O[C@@H]([C@H](C2)C)[C@@H](CC)C(=O)[C@@H](C)[C@@H](O)[C@H](C)CCC=2C(=C(O)C(C)=CC=2)C(O)=O)C[C@](O)(CC)[C@H](C)O1 BBMULGJBVDDDNI-OWKLGTHSSA-N 0.000 description 2
- 229960000320 lasalocid Drugs 0.000 description 2
- 239000006028 limestone Substances 0.000 description 2
- 239000011777 magnesium Substances 0.000 description 2
- 229910052749 magnesium Inorganic materials 0.000 description 2
- 235000012054 meals Nutrition 0.000 description 2
- 239000011707 mineral Substances 0.000 description 2
- 235000010755 mineral Nutrition 0.000 description 2
- 235000013379 molasses Nutrition 0.000 description 2
- 150000002772 monosaccharides Chemical class 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- DANUORFCFTYTSZ-BIBFWWMMSA-N nigericin Chemical compound C([C@@H]1C[C@H]([C@H]([C@]2([C@@H](C[C@](C)(O2)C2O[C@@](C)(CC2)C2[C@H](CC(O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)C)O1)C)OC)[C@H]1CC[C@H](C)C([C@@H](C)C(O)=O)O1 DANUORFCFTYTSZ-BIBFWWMMSA-N 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- ZWLPBLYKEWSWPD-UHFFFAOYSA-N o-toluic acid Chemical group CC1=CC=CC=C1C(O)=O ZWLPBLYKEWSWPD-UHFFFAOYSA-N 0.000 description 2
- 239000011574 phosphorus Substances 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920000728 polyester Polymers 0.000 description 2
- 239000002460 polyether antibiotic agent Substances 0.000 description 2
- 239000002244 precipitate Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 238000011084 recovery Methods 0.000 description 2
- 159000000000 sodium salts Chemical class 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- 239000011573 trace mineral Substances 0.000 description 2
- 235000013619 trace mineral Nutrition 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 235000019166 vitamin D Nutrition 0.000 description 2
- 239000011710 vitamin D Substances 0.000 description 2
- 238000005303 weighing Methods 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 239000002028 Biomass Substances 0.000 description 1
- 241000283707 Capra Species 0.000 description 1
- 241000193403 Clostridium Species 0.000 description 1
- 208000008034 Contagious Ecthyma Diseases 0.000 description 1
- VMQMZMRVKUZKQL-UHFFFAOYSA-N Cu+ Chemical compound [Cu+] VMQMZMRVKUZKQL-UHFFFAOYSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 241001057636 Dracaena deremensis Species 0.000 description 1
- 241000223932 Eimeria tenella Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 206010015137 Eructation Diseases 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N Furan Chemical group C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 206010020710 Hyperphagia Diseases 0.000 description 1
- 235000019687 Lamb Nutrition 0.000 description 1
- HLFSDGLLUJUHTE-SNVBAGLBSA-N Levamisole Chemical compound C1([C@H]2CN3CCSC3=N2)=CC=CC=C1 HLFSDGLLUJUHTE-SNVBAGLBSA-N 0.000 description 1
- WAEMQWOKJMHJLA-UHFFFAOYSA-N Manganese(2+) Chemical compound [Mn+2] WAEMQWOKJMHJLA-UHFFFAOYSA-N 0.000 description 1
- 240000004658 Medicago sativa Species 0.000 description 1
- 235000017587 Medicago sativa ssp. sativa Nutrition 0.000 description 1
- VHKXXVVRRDYCIK-UHFFFAOYSA-N Narasin Natural products CC1CC(C)C(C(CC)C(O)=O)OC1C(C)C(O)C(C)C(=O)C(CC)C1C(C)CC(C)C2(C=CC(O)C3(OC(C)(CC3)C3OC(C)C(O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-UHFFFAOYSA-N 0.000 description 1
- VHKXXVVRRDYCIK-CWCPJSEDSA-N Narasin Chemical compound C[C@H]1C[C@H](C)[C@H]([C@@H](CC)C(O)=O)O[C@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 VHKXXVVRRDYCIK-CWCPJSEDSA-N 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 206010031071 Orf Diseases 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 241001494479 Pecora Species 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- XBDQKXXYIPTUBI-UHFFFAOYSA-N Propionic acid Chemical class CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 1
- 206010037423 Pulmonary oedema Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- KQXDHUJYNAXLNZ-XQSDOZFQSA-N Salinomycin Chemical compound O1[C@@H]([C@@H](CC)C(O)=O)CC[C@H](C)[C@@H]1[C@@H](C)[C@H](O)[C@H](C)C(=O)[C@H](CC)[C@@H]1[C@@H](C)C[C@@H](C)[C@@]2(C=C[C@@H](O)[C@@]3(O[C@@](C)(CC3)[C@@H]3O[C@@H](C)[C@@](O)(CC)CC3)O2)O1 KQXDHUJYNAXLNZ-XQSDOZFQSA-N 0.000 description 1
- 239000004189 Salinomycin Substances 0.000 description 1
- 235000019764 Soybean Meal Nutrition 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 241000186990 Streptomyces cacaoi Species 0.000 description 1
- 241000187391 Streptomyces hygroscopicus Species 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 229930003316 Vitamin D Natural products 0.000 description 1
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 208000021017 Weight Gain Diseases 0.000 description 1
- XSBSGLXIQBCTKN-SARHNJKISA-N X-206 Chemical compound C1C[C@](O)(C)[C@H](CC)O[C@H]1[C@@]1(C)O[C@@](O)([C@@]2(C)O[C@@H](CC2)[C@@H](O)[C@@]2(O)[C@@H](C[C@H](C)[C@@H](C[C@]3(O)[C@H](CC[C@@H](O3)[C@@H](C)[C@H](O)C[C@@H]3O[C@@H]([C@@H](C)CC3)[C@@H](C)C(O)=O)C)O2)C)[C@H](C)C1 XSBSGLXIQBCTKN-SARHNJKISA-N 0.000 description 1
- XSBSGLXIQBCTKN-UHFFFAOYSA-N X-206 Natural products C1CC(O)(C)C(CC)OC1C1(C)OC(O)(C2(C)OC(CC2)C(O)C2(O)C(CC(C)C(CC3(O)C(CCC(O3)C(C)C(O)CC3OC(C(C)CC3)C(C)C(O)=O)C)O2)C)C(C)C1 XSBSGLXIQBCTKN-UHFFFAOYSA-N 0.000 description 1
- PTFCDOFLOPIGGS-UHFFFAOYSA-N Zinc dication Chemical compound [Zn+2] PTFCDOFLOPIGGS-UHFFFAOYSA-N 0.000 description 1
- 150000001242 acetic acid derivatives Chemical class 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 230000006978 adaptation Effects 0.000 description 1
- 239000000654 additive Substances 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 235000021120 animal protein Nutrition 0.000 description 1
- 230000001165 anti-coccidial effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229940036811 bone meal Drugs 0.000 description 1
- 239000002374 bone meal Substances 0.000 description 1
- 150000004648 butanoic acid derivatives Chemical class 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 230000025938 carbohydrate utilization Effects 0.000 description 1
- 125000002091 cationic group Chemical group 0.000 description 1
- 150000001768 cations Chemical class 0.000 description 1
- RNFNDJAIBTYOQL-UHFFFAOYSA-N chloral hydrate Chemical compound OC(O)C(Cl)(Cl)Cl RNFNDJAIBTYOQL-UHFFFAOYSA-N 0.000 description 1
- 229960002327 chloral hydrate Drugs 0.000 description 1
- 150000004695 complexes Chemical class 0.000 description 1
- 201000005332 contagious pustular dermatitis Diseases 0.000 description 1
- 239000002178 crystalline material Substances 0.000 description 1
- 229940075894 denatured ethanol Drugs 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 239000003085 diluting agent Substances 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000006185 dispersion Substances 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 235000019197 fats Nutrition 0.000 description 1
- 235000021050 feed intake Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 239000007789 gas Substances 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 239000007952 growth promoter Substances 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 238000011534 incubation Methods 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 238000002329 infrared spectrum Methods 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 230000005764 inhibitory process Effects 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 238000007918 intramuscular administration Methods 0.000 description 1
- 239000007928 intraperitoneal injection Substances 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 238000011835 investigation Methods 0.000 description 1
- 229910003002 lithium salt Inorganic materials 0.000 description 1
- 159000000002 lithium salts Chemical class 0.000 description 1
- MSBWDNNCBOLXGS-UHFFFAOYSA-L manganese(2+);diacetate;hydrate Chemical compound O.[Mn+2].CC([O-])=O.CC([O-])=O MSBWDNNCBOLXGS-UHFFFAOYSA-L 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 230000002906 microbiologic effect Effects 0.000 description 1
- 229960001851 narasin Drugs 0.000 description 1
- 230000007935 neutral effect Effects 0.000 description 1
- 125000004433 nitrogen atom Chemical group N* 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000000050 nutritive effect Effects 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 235000020830 overeating Nutrition 0.000 description 1
- 238000010979 pH adjustment Methods 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000013641 positive control Substances 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000003334 potential effect Effects 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 235000018102 proteins Nutrition 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 208000005333 pulmonary edema Diseases 0.000 description 1
- 150000004728 pyruvic acid derivatives Chemical class 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 229960001548 salinomycin Drugs 0.000 description 1
- 235000019378 salinomycin Nutrition 0.000 description 1
- XOIQMTLWECTKJL-BEMBKCOJSA-M sodium;(2s,3r,4s)-4-[(2s,7s,8r,9s)-2-[(2r,5s)-5-ethyl-5-[(2r,3s,5r)-5-[(2s,3s,5r,6r)-6-hydroxy-6-(hydroxymethyl)-3,5-dimethyloxan-2-yl]-3-methyloxolan-2-yl]oxolan-2-yl]-7-hydroxy-2,8-dimethyl-1,10-dioxaspiro[4.5]decan-9-yl]-3-methoxy-2-methylpentanoate Chemical compound [Na+].C([C@@](O1)(C)[C@H]2CC[C@@](O2)(CC)[C@H]2[C@H](C[C@@H](O2)[C@@H]2[C@H](C[C@@H](C)[C@](O)(CO)O2)C)C)CC21C[C@H](O)[C@@H](C)[C@@H]([C@@H](C)[C@@H](OC)[C@H](C)C([O-])=O)O2 XOIQMTLWECTKJL-BEMBKCOJSA-M 0.000 description 1
- DGPIGKCOQYBCJH-UHFFFAOYSA-M sodium;acetic acid;hydroxide Chemical compound O.[Na+].CC([O-])=O DGPIGKCOQYBCJH-UHFFFAOYSA-M 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000004455 soybean meal Substances 0.000 description 1
- 235000012424 soybean oil Nutrition 0.000 description 1
- 239000003549 soybean oil Substances 0.000 description 1
- 241000894007 species Species 0.000 description 1
- 238000007920 subcutaneous administration Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 235000021195 test diet Nutrition 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 150000003710 vitamin D derivatives Chemical class 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940046001 vitamin b complex Drugs 0.000 description 1
- 229940046008 vitamin d Drugs 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000004584 weight gain Effects 0.000 description 1
- 235000019786 weight gain Nutrition 0.000 description 1
- 229940006486 zinc cation Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H23/00—Compounds containing boron, silicon or a metal, e.g. chelates or vitamin B12
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/195—Antibiotics
Landscapes
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Biochemistry (AREA)
- Food Science & Technology (AREA)
- Health & Medical Sciences (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Animal Husbandry (AREA)
- Fodder In General (AREA)
- Feed For Specific Animals (AREA)
Abstract
The growth and feed efficiency of food producing domestic mammals (especially ruminants) is improved by administering, a growth- promoting amount of the antibiotic lysocellin or a physiologically acceptable salt or metal complex thereof. Preferred metal complexes or salts of lysocellin are the sodium zinc, copper, and manganese derivatives.
Description
SPECIFICATION
Process for promoting growth and feed efficiency of food producing mammals
The present invention relates to an animal growth promoting process which itilizes certain forms of lysocellin as a growth-promoting substance in food-producing mammals such as is disclosed in the specification of Application No. 8021437.
A fairly comprehensive review of the various classes of polyester antibiotics is set forth in
Westley, Adv. Appl. Microbiology 22, 177-223 (1977). Lysocellin falls into Class 2a as defined by Westley. Class 2a comprises divalent polyesters of a linear configuration which may contain from about two or about three tetrahydropyran and/or furan structures, up to three total ring structures and no nitrogen atoms. Table VIII of the Westley publication discloses the effective level of lysocellin as a coccidiostat. Lysocellin at 300 ppm in feed was said to be effective against Eimeria tenella. The reference refers to the use of lysocellin in poultry feed, and the level of Iysocellin required to function as a coccidiostat considerably greater than other polyether antibiotics, such as monensin, nigericin, lasalocid and others.
Lysocellin was first reported in the literature by Ebata, et al, The Journal of Antibiotics 28 (2): 118-121, 1975. The physico-chemical properties of lysocellin are described there, including a melting point of about 158-160 C. of the colorless needles of the sodium salt. The antibiotics is said to be produced from a mutant strain of Streptomyces cacaoi var. asoensis designated
Streptomyces cacaoivar. asoensis K-9 Met-, but this strain has apparently not been made available to the public. This reference discloses that lysocellin is active against gram-positive bacteria, antibiotic resistant Staphylococcus aureus, some fungi, but that it is not active against gram-negative bacteria. There is no disclosure here of any use of lysocellin in meat-producing animals.
The structural formula for lysocellin was set forth by Otake, et al, Agric. Biol. Chem. 42 (10): 1879-1877, 1 978. This reference also reports that lysocellin is effective in treating coccidial infections in poultry, but there is no mention here of any other use of lysocellin in meatproducing animals.
United States Patent 4,033,823, issued July 3, 1977, to Liu, et al, discloses the structural formula of lysocellin and a method for making it using Streptomyces longwoodensis (ATCC 29251). This patent only describes the use of lysocellin as an antimicrobial.
More recently, lysocellin was compared to a number of other polyether antibiotics for inhibition of ruminal degradation of L-tryptophan (TRP) to 3-methylindole (3MI) in vitro. Other polyether antibiotics used for the comparison included desoxysalinomycin, X-206, nigericin, lasalocid, monensin, narasin and salinomycin. Chloral hydrate was also used. The study was aimed at determining the potential effect of these antibiotics in the treatment of acute bovine pulmonary edema and emphysema (ABPE), or "fog fever", which appears to relate to ruminal production of 3MI. Hammond, et al, Journal of Animal Science 51(1): 207-214, 1980.
The above study by Hammond, et al, reported that the polyether antibiotics tested were the most effective compounds in reducing in vitro ruminal degradation of TRP to 3MI without significant decrease in VFA production. However, lysocellin was reported as one of the least effective of the polyether antibiotics tested for this purpose. This publication concludes that "further investigations of the effects of monensin on live animals are warranted". No further work with lysocellin was recommended by the authors. It should be noted that monensin did depress the VFA production in this test, and that its use as a feed additive is only for improved feed efficiency or utilization. See: United States Patent 3,839,557.
United States Patent 4,129,578, discloses the use of Compound 38,295 (etheromycin) as having anticoccidial, antimicrobial and growth promotant properties. Various cationic salts of etheromycin are disclosed, including copper, zinc, ammonium, calcium, magnesium and lithium salts. However, the microorganism, Streptomyces hygroscopicus ATCC 31050 used in the above reference has been withdrawn from the culture collection, so the reference is not believed to be "enabling" as to the growth promoting effects disclosed. In any event, the patent discloses only the use of etheromycin (Antibiotic 38,295 derived from ATCC 31050).
Recently issued United States Patent 4,221,724 Liu et al, discloses the use of polyether antibiotic X-14766A as a growth promotant for ruminants. However, the only results reported in this patent were for in vitro volatile fatty acid production. Although such tests may give an indication that a substance will be effective as a growth promotant in ruminants, this is not conclusive, and actual in vitro testing is necessary. The molecular structure of X-14766A is different from lysocellin. X-14766A includes a chloride group on a methylbenzoic acid group, there are forty-three carbon atoms in the molecule, and there are four successive heterocyclic polyether rings, whereas lysocellin contains only two successive heterocyclic polyether rings, contains neither chloride groups, nor a methylbenzoic acid group.In addition, lysocellin has a total of only thirty-four carbon atoms in the molecule.
It has now been surprisingly discovered that the various forms of lysocellin act as especially effective growth-promoting and feed efficiency-enhancing agents when administered to foodproducing mammals such as ruminants. In ruminants having a developed rumen function, including cattle, sheep and goats, the various forms of lysocellin are believed to promote growth and enhance the efficiency of feed utilization in the animal by lowering the acetate/propionate ratio among the volatile fatty acids (VFA) found in the animal's rumen fluid. The relationship between acetate/propionate ratio in the rumen and feed efficiency in the ruminant animals is explained in greater detail in Raun, U.S. Patent 3,794,732 issued February 26, 1974.
Therefore, the present invention relates to processes for promoting growth and enhancing feeding efficiency in food-producing mammals by administering various forms of lysocellin to meat-producing animals, particularly ruminants. Among the useful forms of lysocellin are: the free acid and the pharmaceutically acceptable salts, including sodium, zinc, manganese, magnesium and copper salts. Zinc, manganese and copper are believed to form salt "com plexes", and two of the linear polyether molecules "wrap" around the bivalent cation.
In accordance with the present invention, the zinc, manganese, or copper complexes of lysocellin can be formed by adding water-soluble zinc, manganese or copper salts to the fermentation broth in which lysocellin has been prepared, and the resulting broth-insoluble zinc, manganese or copper complexes of lysocellin can then be recovered from the broth and employed as growth-promoting and feed-efficiency enhancing additives, especially in feed for food-producing mammals such as ruminants, swine and poultry.
Lysocellin-containing fermentation broth is prepared in conventional manner by fermenting a nutrient-containing liquid fermentation medium inoculated with a Streptomyces longwoodensis (ATCC 29251) which is capable of producing lysocellin. Suitable liquid fermentation media are generally aqueous dispersions containing a nitrogen source and a carbohydrate source. Nitrogen sources for use in the fermentation media herein can include, for example, sugar, molasses, cornsteep liquor and the like. The fermenation media can also contain a variety of optional ingredients, if desired, such as for example, pH adjustment agents, buffers, trace minerals, antifoam agents, filter aids, etc.
The Streptomyces microorganism is grown in an aerated, agitated, submerged culture with the pH of the broth adjusted to about neutral, i.e., from a pH value of about 6.5 to about 7.5.
Fermentation can generally be carried out at slightly elevated temperatures, e.g., between about 25"C and 35"C. Incubation of the broth can be carried out for a period of several days e.g., from about 4 to 6 days or longer if it is economically advantageous to do so.
A particular method for producing the antibiotic lysocellin was disclosed by Liu et al in U.S.
Patent 4,033,823, by the cultivation of a strain of Streptomyces longwoodensis which is on unrestricted deposit at the American Type Culture Collection under the designation ATCC 29251. The structure of lysocellin is as follows:
Lysocellin
Suitable methods for preparing the lysocellin antibiotic are set forth in the above-mentioned patent. The characteristics of lysocellin were first set forth in the article by Ebata et al, J.
Antibiotics 28:118-121, 1975.
The various forms of lysocellin, including the free acid, sodium salts, and the zinc, manganese, and copper lysocellin complexes used in the present invention act as growthpromoting agents in food-producing mammals, e.g., ruminants, swine and poultry. These forms of lysocellin can be administered to food-producing animals, either orally, subcutaneously or parenterally, in amounts sufficient to enhance the growth rate of the animals The amount of the lysocellin material administered to an animal varies, of course, with the species of animal, the desired rate of growth, and the like. The material is frequently administered to ruminants in an amount of about 1 to 200, preferably about 1. to 50 milligrams per head per day.
Preferably, the lysocellin material is administered to food-producing animals in their feed, and can be conveniently added to animal feed in the form of the dried, anti-biotic-containing biomass which is recovered as a feed additive composition from the fermentation broth as hereinbefore described. It may also be administered in liquid feeds, and in the animals's drinking water.
A feed composition may be prepared containing the usual nutritionally-balanced quantities of carbohydrates, proteins, vitamins and minerals as diluents together with the lysocellin material.
Some of the usual sources of these dietary elements are grains, such as ground grain and grain by-products; animal protein substances, such as those found in fish meal and meat scraps; vegetable proteins, such as soybean oil meal or peanut oil meal; vitaminaceous materials, e.g., mixture of vitamins A and D, riboflavin supplements and other vitamin B complex members; and bone meal and limestone to provide minerals. A type of conventional feed material for use with cattle, for example, includes alfalfa hay and ground corn cobs, together with supplementary vitaminaceous substances if desired. The lysocellin materials of the present invention can generally be employed in the feed compositions to the extent of from about 1 5 grams per ton to 200 grams per ton, preferably from about 75 grams per ton to 125 grams per ton.
The lysocellin growth-promoting agents described herein, can also be administered to foodproducing animals subcutaneously or parenterally in combination with a pharmaceuticallyacceptable carrier. For example, the lysocellin materials can be employed in an injection composition, or as an implant under the skin. Administration of the growth-promoting agents herein in this manner can include intra-muscular, intravenous, subcutaneous, and intraperitoneal injections. When an implant is used, for example, a ball or cylindrical implant inserted under the skin on the ear of an animal, the implant will generally contain from about 1 mg to 100 mg of one of the lysocellin materials.
The various lysocellin materials, their preparation and recovery and the feed and feed additive compositions involved in the present invention as well as their usefulness as growth promoting agents for ruminants are illustrated by the following examples. Such examples include the preparation, recovery and evaluation of the preferred lysocellin material, but are in no way limiting of the present invention to processes involving that particular material.
EXAMPLE I
Crystalline sodium lysocellin was produced following the fermentation method set forth in
Example I of U.S. Patent 4,033,823, issued July 5, 1977; which procedure is incorporated herein by reference. The melting point of the resultant crystalline sodium lysocellin isolated from the fermentation broth was 159.6 (Mettler). Infra-red spectrum and optical rotation agree with the date for sodium lysocellin published by Otake, et al, op. cit. NMR spectra and elemental analysis of the crystalline material obtained by the above method confirmed that the product was sodium lysocellin.
EXAMPLE II
Sodium lysocellin produced by the method of Example I was used to make the free acid of lysocellin 5 as follows: 3.9 g sodium lysocellin @ ( (0.006 (0.006 moles) and 1.4 g zinc acetate hydrate [Zn(Ac)2.2H20] @ (.006 mole) were mixed together in 30 ml denatured ethanol (3A). The sodium lysocellin was first suspended in the ethanol and stirred, and the sodium acetate hydrate was added, and the suspension stirred at room temperature until everythin was dissolved. The pH was then adjusted to a range of 2-4, with 37% HCI. Stirring was continued for 20-30 minutes until precipitation of a birefringent material started. Precipitation was continued by adding water dropwise (holding pH at 4) until about 60 ml of water was added. The resulting crystalling precipitate of the free acid of lysocellin was isolated and dried.The resulting free acid of lysocellin comprised birefringent crystals.
The above material was again dissolved in ethanol and recrystallized from ethanol by again adding water dropwise until the free acid of lysocellin precipitated out as birefringent crystals.
The melting point of this material was 147.5"C (Mettler), and the analysis (percent by weight) was C, 65.45% H, 9.57%; and 0, 24.90% and showed the molecule to comprise C34H6001o (lysocellin, free acid).
EXAMPLE 111
The sodium lysocellin made according to the method of Example I was used to make the crystalline zinc salt of lysocellin by the following method:
1.3 g of sodium lysocellin and 0.5 g of zinc acetate hydrate [Zn(Ac)2, 2H2O] were added to 1 5 ml of acetone. The reactants were stirred at room temperature until all solids were in solution. Stirring was continued, and 30 ml of water was added dropwise to cause precipitation of the zinc salt complex of lysocellin. The crystalline precipitate was isolated and dried, redissolved in acetone and then recrystallized using the above procedure to yield the crystalline zinc lysocellin salt complex. The melting point of this material was 109.5"C (Mettler).The analysis was: C, 59-77%; H, 8.94%; 0, 23.65%; Zn, 4.37%; indicating that two molecules of lysocellin are tied up with one zinc cation is the zinc salt complex as follows: (C34H59Oa0)2Zn.
EXAMPLE IV
Example Ill was repeated, except that zinc acetate hydrate was replaced by manganese acetate hydrate. The resulting manganese salt complex of lysocellin was amorphous, and had an analysis of 3.73% Mn, indicating that two molecules of lysocellin are tied up by one bivalent manganese cation as follows: (C34H59010)2Mn.
EXAMPLE V
The method of Example Ill was repeated, except that the zinc acetate hydrate was replaced by cupric acetate hydrate [Cu(Ac)2.2H2O]. A mixture of 2.6 g of sodium lysocellin, 1.0 g cupric acetate hydrate and 50 ml of acetone was stirred until solution was complete. Stirring was continued, and water (2 col) was added dropwise. The copper salt complex of lysocellin was precipitated, isolated and recrystallized from aqueous acetone. The crystalline copper salt complex of lysocellin has a melting point of 119-122 C and it has 3.68% Cu, indicating there are two molecules of lysocellin tied up by one bivalent copper cation as follows: (C34H59010)2Cu.
EXAMPLE VI
The in vitro rumen fermentation test described below can be used to accurately predict the improved feed utilization effects of test compounds fed to ruminants.
Microorganisms in the rumen of the animal ferment carbohydrates to produce monosaccharides and then degrade the monosaccharides to pyruvate compounds. Pyruvate is then metabolized by microbiological processes to either acetate or proprionate compounds. These compounds may be either acids or other forms of the radicals. Two acetate compounds may be combined still in the rumen to form butyrates.
The animal can utilize butyrate, propionate and acetate with differing degrees of efficiency.
Butyrate is utilized most efficiently and acetate the least efficiently. The relative efficiency of butyrate is negated because it is made from acetate in the rumen.
One of the major inefficiencies in the rumen is in the manufacture of acetate. Since it is made by the degradation of a pyruvate molecule, each molecule of acetate produced is accompanied by a molecule of methane. Most of the methane produced is lost through eructation. Each molecule of butyrate used involves the loss of two molecules of methane with all its associated energy.
Thus, the efficiency of carbohydrate utilization (carbohydrates being the major nutritive portion of animal's feed) can be increased by treatments which encourage the animal to produce propionate rather than acetate from the carbohydrates.
The efficiency of feed use can be effectively monitored by observing the production and concentration of propionate compounds in the rumen. If the animal is making more propionate, it will be found to be using its feed more efficiently. This efficiency is manifested by greater weight gains per feed intake, a reduction in energy losses by methane release, and economic advantages to the animal grower when the animal is sold for consumption.
Procedure
Rumen fluid was removed from a fistulated steer and strained through cheesecloth. An equal amount of pH 7 buffer was added to the strained rumen fluid. After layering occurred, the lower layer was saved and again diluted with an equal amount of butter.
Ten ml portions of the buffered rumen fluid were added to fermentation vessels containing 500 mg of fresh finely ground cattle ration, 1 mg of cellubiose, and amounts of the test compounds that resulted in a 5 ppm concentration.
The vessels were outfitted with one way gas valves and placed in an incubator shaker for 24 hours at 38"C. Fermentation was stopped by the addition of one ml of mercuric chloride.
The liquid was decanted and analyzed for volative fatty acid by gas chromatography.
Conclusions
Changes in the acetate/propionate ratio caused by six forms of the polyether antibiotic lysocellin were determined by the above in vitro methods. The acetate/propionate weight ratios given are from means of 10 tests for each compound.
Ex. I Ex. II Ex. III Ex. IV Ex. V
Positive Lyso- Lyso- Lyso- Lyso- Lyso
Negative Control cellin cellin cellin cellin cellin
Control Monensin Na Free Acid Zn Mn Cu 2.04 1.38 1.24 1.26 1.24 1.26 1.22
All forms of lysocellin tested were more effective than the positive control, monensin, in increasing the relative amount of propionate. From these results it can be concluded that all forms of lysocellin can be expected to improve feed efficiency when fed to ruminants. The fact that all forms of lysocellin performed substantially better than monensin would also indicate a possible effect as a growth promoter.
EXAMPLE VII
Twenty-five Columbia wether lambs were received and adapted to the basal ration set forth below in Table 1.
Table 1
Composition of the Basal Ration Wether Lamb Test
International
Reference No. Per Cent
Corn, cracked shelled 4-20-931 68.7
Alfalfa-whole corn plants
dehydrateda 20.0
Soybean meal (44%) 5-20-637 7.5
Cane molasses 4-04-696 2.0
Limestone 6-02-632 0.8
Trace mineral saltb 0.6
Vitamin premixC 0.4
Calculated composition
(as fed basis)
Crude protein 11.9
Crude fiber 6.8
Calcium 0.48
Phosphorus 0.28
Potassium 0.73
Sulfur 0.27
Digestible energy 3.08 Mcal/kg aCharles H. Schenk and Sons, Inc., Vincennes, Indiana. Guaranteed analysis: crude protein, min. 12.00%; crude fiber, max. 25.00%; fat, min. 1.50%; calcium, min. 0.75%, Max.
0.87%; and phosphorus, min. 0.20%.
bComposition: NaCI, not > 99.0%; not < 0.35% Zn, 0.34%
Fe,0.200% Mn, 0.033% Cu, 0.077% 1, and 0.005% Co.
CProvides per kg of diet: 2750 IU vitamin A; 700 IU vitamin
D, and 10 IU vitamin E.
Animals
Six days after arrival, the lambs were weighed tagged, treated with Tramisol wormer and vaccinated for both contagious ecthyma (soremouth) and Clostridium perfringes type D (overeat ing disease). Following adaptation, the lambs were reweighed. The lambs were then randomly assigned to five pens (five lambs per pen), providing approximately 1.42 sq. m. per animal.
During the following eight-week experimental period, water and feed were available ad libitum.
Compounds Tested
There were four lysocellin materials tested, and a negative control. The test diets and control were each administered to five animals over the eight week test period. Each test ration contained the designated lysocellin compound at a level of 30g/ton.
Procedures
The lambs were weighed initially, and bi-weekly thereafter for the duration of the eight week experiment. The lambs were fasted for eighteen hours prior to weighing. Orts were weighed back at 3:00 P.M. the day prior to weighing the animals.
The effect of the dietary treatments is shown in the following Table 2.
Effects of Addition to Ration of Various Lysocellin Materials in Wether Lambs
Sodium Zinc Lyso- Manganese
Lyso- Lyso- cellin Lyso
Effect Observed Control cellin cellin (Free Acid) cellin
Avg. Daily Gain (kg/day/head) 0.206 0.198 0.204 0.198 0.235
Gain/Feed 0.148 0.157 0.155 0.53 0.171
Of the above treatments, manganese lysocellin was most effective in increasing gain (growth promotion) and feed efficiency. Each of the test compositions showed some improvement in feed efficiency (gain/feed), and it is expected that when the dosage for each lysocellin material is optimized, all lysocellin materials will show an increase in gain (growth promotion) comparable, or better than, that observed for the manganese lysocellin material.
The zinc, manganese or copper lysocellin-containing feed composition is fed to cattle in amounts sufficient to provide from about 5 to 100 ppm of zinc, manganese or copper lysocellin in the rumen fluid. Administration of the zinc, manganese or copper lysocellin material in this manner serves to promote cattle growth by enhancing the efficiency with which the cattle so treated utilize their feed without suppressing appetite.
Claims (11)
1. An improvement in or modification of the process for promoting growth and enhancing feed efficiency of food-producing mammals of Application No. 8021437 which process comprises administering to food-producing mammals a growth-promoting and feed efficiencyenhancing amount of a lysocellin material selected from the group consisting of lysocellin, lysocellin fee acid, and the physiologically acceptable salts thereof.
2. A process in accordance with Claim 1 wherein the lysocellin material is selected from the sodium, zinc, manganese and copper lysocellin salts.
3. A process in accordance with Claim 1 or 2 wherein the lysocellin material is administered parenterally.
4. A process in accordance with Claim 1, 2 or 3 wherein the food-producing mammals are ruminants, and the lysocellin material comprises a metal salt complex this is administered as part of an animal feed composition containing from about 1 to 200 grams of the lysocellin material per ton of feed.
5. A process in accordance with Claim 4, wherein the animal feed composition is fed to ruminants at a rate sufficient to provide for about 1 5 to 200 milligrams of the lysocellin material per head per day.
6. A process in accordance with Claim 4 wherein the lysocellin material is a metal lysocellin material, and is administered in amounts sufficient to provide from about 5 to 100 ppm of metal lysocellin in the rumen fluid contents.
7. A process in accordance with Claim 6 wherein the lysocellin material comprises manganese lysocellin, and is administered in amounts sufficient to provide from about 5 to 100 ppm of manganese lysocellin in the rumen fluid contents.
8. A process in accordance with Claim 6 wherein the lysocellin material is zinc lysocellin and is administered in amounts sufficient to provide from about 5 to 100 ppm of zinc lysocellin in the rumen fluid contents.
9. An improvement in or modification of the feed supplement of Application No. 8021437 capable of increasing the rate of growth of the animal when supplied in the animal's feed on a regular basis during the animal's normal growth period, and is also capable of enhancing feed efficiency of the animal, said feed supplement comprising a lysocellin material selected from the group consisting of lysocellin, lysocellin free acid, and the physiologically acceptable salts thereof.
10. The animal feed supplement of Claim 9 in which the lysocellin material is selected from the sodium, zinc, manganese and copper lysocellin salts.
11. The animal feed supplement of Claim 9 or 10 in which the lysocellin material is administered parenterally.
1 2. The animal feed supplement of Claim 9, 10, or 11, in which the animal feed composition is fed to ruminants at a rate sufficient to provide for about 1 5 to 200 milligrams of the lysocellin material per head per day.
1 3. The animal feed supplement of Claim 9 in which the lysocellin material is a metal lysocellin material, and is administered in amounts sufficient to provide from about 5 to 100 ppm of metal lysocellin in the rumen fluid contents.
1 4. The animal feed supplement of Claim 1 3 in which the lysocellin material comprises manganese lysocellin, and is administered in amounts sufficient to provide from about 5 to 100 ppm of manganese lysocellin in the rumen fluid contents.
1 5. The animal feed supplement of Claim 14, in which the lysocellin material is zinc lysocellin.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US29113481A | 1981-08-07 | 1981-08-07 |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2107585A true GB2107585A (en) | 1983-05-05 |
GB2107585B GB2107585B (en) | 1985-02-20 |
Family
ID=23119004
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08217753A Expired GB2107585B (en) | 1981-08-07 | 1982-06-18 | Animal feed supplements containing lysocellin |
Country Status (4)
Country | Link |
---|---|
AU (1) | AU559508B2 (en) |
CA (1) | CA1220664A (en) |
GB (1) | GB2107585B (en) |
IE (1) | IE54167B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014195855A1 (en) * | 2013-06-06 | 2014-12-11 | Rich Technology Solutions Limited | The use of a feed supplement for ruminants |
-
1982
- 1982-06-18 GB GB08217753A patent/GB2107585B/en not_active Expired
- 1982-06-23 AU AU85119/82A patent/AU559508B2/en not_active Ceased
- 1982-06-24 IE IE1512/82A patent/IE54167B1/en unknown
- 1982-06-25 CA CA000406021A patent/CA1220664A/en not_active Expired
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2014195855A1 (en) * | 2013-06-06 | 2014-12-11 | Rich Technology Solutions Limited | The use of a feed supplement for ruminants |
CN105307503A (en) * | 2013-06-06 | 2016-02-03 | 里奇技术解决方案公司 | The use of a feed supplement for ruminants |
Also Published As
Publication number | Publication date |
---|---|
AU8511982A (en) | 1983-02-10 |
CA1220664A (en) | 1987-04-21 |
GB2107585B (en) | 1985-02-20 |
AU559508B2 (en) | 1987-03-12 |
IE54167B1 (en) | 1989-07-05 |
IE821512L (en) | 1983-02-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chalupa | Manipulating rumen fermentation | |
US3839557A (en) | Antibiotics monensin and a204 for improving ruminant feed efficiency | |
KR840000750B1 (en) | Poly-ether compounds | |
CA1238316A (en) | Aglycone and pseudo-aglycones of the aad 216 antibiotics | |
EP1442664B1 (en) | A method for supplying biovailable methionine to a cow | |
JPS5929621A (en) | A47934 antibiotic and manufacture | |
US4336250A (en) | Lactation improvement method | |
US4478935A (en) | Manganese-containing antibiotic agents | |
US4761426A (en) | Lysocellin-containing composition and process for promoting growth and feed efficiency of food producing animals | |
JPH09187229A (en) | Feed composition for poultry | |
US4430328A (en) | Ruminant lactation improvement | |
JP5192108B2 (en) | Composition for inhibiting methanogenesis and composition for feed for ruminants | |
US4933364A (en) | Process for promoting growth and feed efficiency of food producing mammals | |
EP0091649A1 (en) | Method for increasing the efficiency of rumen fermentation of ruminant animals | |
JP2535544B2 (en) | Antibiotics LL-E19020 α and β | |
US4904689A (en) | Lysocellin-containing feed efficiency-enhancing animal feed | |
US4693992A (en) | Bacitracin-metal-polyether antibiotic complexes | |
CA1220664A (en) | Process for promoting growth and feed efficiency of food producing mammals | |
US4892960A (en) | Crystalline lysocellin compositions and method of making | |
US4654334A (en) | Manganese-containing antibiotic agents | |
US4225593A (en) | Growth promotion | |
US4670260A (en) | Antibiotic for animal feeds | |
US5081146A (en) | Method and feed supplement for the feeding of ruminants | |
US4567173A (en) | Pyridine, 2,2'-(2-imidazolidinylidene)di-, copper iron and nickel complexes and use in animals | |
EP0063491B1 (en) | Ruminant lactation improvement |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980618 |